Porous silicon manufactured in a bottom-up procedure using solar energy can be used to generate hydrogen from water, according to a team of Penn State mechanical engineers, who also see applications for batteries, biosensors and optical electronics as outlets for this new material.

A not-for-profit bioscience information service, from Cold Spring Harbor Laboratory.

The Environmental Protection Agency’s (EPA’s) recommendations for treating water after a natural disaster or other emergencies call for more chlorine bleach than is necessary to kill disease-causing pathogens and are often impractical to carry out, a new study has found.

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

The proportion of land used to cultivate shade grown coffee, relative to the total land area of coffee cultivation, has fallen by nearly 20 percent globally since 1996, according to a new study by scientists from the University of Texas at Austin and five other institutions

Johns Hopkins computer scientists have found a flaw in the way that secure cloud storage companies protect their customers' data, a weakness they say jeopardizes the privacy protection these digital warehouses claim to offer.

Research in Journal of Food Protection finds antibacterial soap significantly reduces risk of illness compared to non-antibacterial soap.

Art of Science: Images from the Institute for Genomic Biology.

4D Technology has announced the inaugural BioCam QPM Research Awards Contest, created to spur biologically important applications of Quantitative Phase Microscopy (QPM) technology.

Anasys Instruments Corp. has licensed a Department of Energy Oak Ridge National Laboratory technology that allows for simultaneous chemical and physical characterization and could lead to advances in materials and drug development.

UD researchers demonstrate that processing can affect size of nanocarriers for targeted drug delivery.

Scientists have identified two unlikely partners in a type of immune cell called a macrophage that work together in response to cancer drugs to increase inflammation in a way that may alter tumor growth. Researchers from the National Institutes of Health published the study in the journal Cancer Research.